ARTICLE | Clinical News
Biosimilar trastuzumab regulatory update
May 30, 2016 7:00 AM UTC
3SBio’s Sunshine Guojian Pharmaceutical Co Ltd. subsidiary withdrew an NDA from China Food and Drug Administration (CFDA) for Ipterbin, a biosimilar of Herceptin trastuzumab, to treat metastatic brea...